The Role of Aspergillus Antibody Detection in Allergic Bronchopulmonary Aspergillosis
DOI:
https://doi.org/10.59188/eduvest.v4i10.39022Keywords:
ABPA, Aspergillus, Immune Response, Antibody, ImmunoglobulinAbstract
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic lung disorder characterized by an exaggerated immune response to fungal allergens, particularly from Aspergillus fumigatus. ABPA leads to excessive mucus production and impaired mucociliary clearance. When A. fumigatus conidia are inhaled, they germinate, release exoproteases and other substances that further impede mucociliary clearance, and activate the immune response. The immune response is known by an exaggerated Th2 response to Aspergillus antigens, leading to production of IgE antibodies, eosinophilic infiltration of the lungs, and the formation of immune complexes. These immune complexes can deposit in the lung tissue, leading to airway inflammation, bronchiectasis, and fibrosis. This disease mainly occurs in individuals diagnosed with bronchial asthma and cystic fibrosis. Increased levels of A. fumigatus total IgE and specific IgE, IgG, and IgA antibodies, play a role in diagnosing patients with ABPA.
References
Agarwal, R., Aggarwal, A. N., Garg, M., Saikia, B., & Chakrabarti, A. (2014). Cut‐off values of serum IgE (total and A. fumigatus‐specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses, 57(11), 659–663.
Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & Group, A. C. A. I. W. (2013). Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clinical & Experimental Allergy, 43(8), 850–873.
Agarwal, R., Sehgal, I. S., Dhooria, S., & Aggarwal, A. N. (2016). Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Review of Respiratory Medicine, 10(12), 1317–1334.
Agarwal, R., Sehgal, I. S., Dhooria, S., Muthu, V., Prasad, K. T., Bal, A., Aggarwal, A. N., & Chakrabarti, A. (2020). Allergic bronchopulmonary aspergillosis. Indian Journal of Medical Research, 151(6), 529–549.
Asano, K., Hebisawa, A., Ishiguro, T., Takayanagi, N., Nakamura, Y., Suzuki, J., Okada, N., Tanaka, J., Fukutomi, Y., & Ueki, S. (2021). New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. Journal of Allergy and Clinical Immunology, 147(4), 1261–1268.
Barry, J., Gadre, A., & Akuthota, P. (2020). Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases. Current Opinion in Immunology, 66, 129–135.
Croft, C. A., Culibrk, L., Moore, M. M., & Tebbutt, S. J. (2016). Interactions of Aspergillus fumigatus conidia with airway epithelial cells: a critical review. Frontiers in Microbiology, 7, 472.
Denning, D. W., Pleuvry, A., & Cole, D. C. (2013). Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Medical Mycology, 51(4), 361–370.
Dietschmann, A., Schruefer, S., Krappmann, S., & Voehringer, D. (2020). Th2 cells promote eosinophil‐independent pathology in a murine model of allergic bronchopulmonary aspergillosis. European Journal of Immunology, 50(7), 1044–1056.
Greenberger, P. A., Bush, R. K., Demain, J. G., Luong, A., Slavin, R. G., & Knutsen, A. P. (2014). Allergic bronchopulmonary aspergillosis. The Journal of Allergy and Clinical Immunology: In Practice, 2(6), 703–708.
Kurup, V. P. (2005). Aspergillus antigens: which are important? Medical Mycology, 43(Supplement_1), S189–S196.
Kurup, V. P., Knutsen, A. P., Moss, R. B., & Bansal, N. K. (2006). Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clinical and Molecular Allergy, 4, 1–7.
Manti, S., Parisi, G. F., Papale, M., Licari, A., Chiappini, E., Mulè, E., Rotolo, N., & Leonardi, S. (2020). Allergic bronchopulmonary aspergillosis in children. Pediatric Allergy and Immunology, 31, 20–22.
Maturu, V. N., & Agarwal, R. (2015). Prevalence of A spergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta‐analysis. Clinical & Experimental Allergy, 45(12), 1765–1778.
Muthu, V., Sehgal, I. S., Prasad, K. T., Dhooria, S., Aggarwal, A. N., Garg, M., Chakrabarti, A., & Agarwal, R. (2020). Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: a distinct subset of ABPA with a lesser risk of exacerbation. Medical Mycology, 58(2), 260–263.
Overton, N. L. D., Denning, D. W., Bowyer, P., & Simpson, A. (2016). Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study. Allergy, Asthma & Clinical Immunology, 12, 1–13.
Patel, A. R., Patel, A. R., Singh, S., Singh, S., & Khawaja, I. (2019). Diagnosing allergic bronchopulmonary aspergillosis: a review. Cureus, 11(4).
Sehgal, I. S., Dhooria, S., Behera, D., & Agarwal, R. (2016). Allergic bronchopulmonary aspergillosis complicating Swyer-James-Macleod’s syndrome: case report and review of literature. European Annals of Allergy and Clinical Immunology, 48(3), 99–102.
Shah, A., & Panjabi, C. (2014). Allergic aspergillosis of the respiratory tract. European Respiratory Review, 23(131), 8–29.
Tracy, M. C., Okorie, C. U. A., Foley, E. A., & Moss, R. B. (2016). Allergic bronchopulmonary aspergillosis. Journal of Fungi, 2(2), 17.
Published
Issue
Section
License
Copyright (c) 2024 Aqidatul Islamiyyati Elqowiyya, Anna Rozaliyani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
